MedPath

Control of breathing and measurement of disease severity in premature infants with chronic lung disease

Not Applicable
Recruiting
Conditions
Bronchopulmonary dysplasia
Prematurity
Respiratory - Other respiratory disorders / diseases
Reproductive Health and Childbirth - Complications of newborn
Registration Number
ACTRN12613000124730
Lead Sponsor
The Ritchie Centre, Monash University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
24
Inclusion Criteria

Preterm infants < 29 weeks gestation.
1. Healthy preterm infant (<29 weeks) without BPD

Infants with BPD defined as need for oxygen or respiratory support at 36 weeks completed postmenstrual age (PMA).

Infants will be further subdivided into
2. Mild BPD (no need for oxygen or respiratory support at 36 weeks PMA but need for either at 28 days of age).

3. Moderate BPD - need for supplemental oxygen (<30%) at 36 weeks PMA butself-ventilating

4. Severe BPD - need for supplemental oxygen (>30%) at 36 weeks PMA or needing respiratory support.

Infants in Group 1, the healthy preterm infant will be the control group while infants in Groups 2 to 4 with mild/moderate/severe BPD will be in the intervention group

Exclusion Criteria

Infants with congenital heart disease
Infants with major congenital anomalies

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath